Guohan Hu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
Papers in
-
- Ubiquitin and proteasome pathways 7
- Cancer-related gene regulation 6
- Circular RNAs in diseases 5
-
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 6
- Co-authors
- Yicheng Lu (38 shared papers)Chun Luo (24 shared papers)Juxiang Chen (16 shared papers)Lei Jiang (19 shared papers)Xuehua Ding (14 shared papers)Juxiang Chen (8 shared papers)Lijun Hou (5 shared papers)Weiqing Li (5 shared papers)
- Journals
- PLoS ONE (6 papers)Brain Research (4 papers)Cellular and Molecular Neurobiology (3 papers)Journal of Neuro-Oncology (2 papers)Oncology Reports (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Guohan Hu
63 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 97
- Cancer Research 529
- Molecular Biology 987
- Genetics 146
- Neurology 159
- Oncology 220
Countries citing papers authored by Guohan Hu
This map shows the geographic impact of Guohan Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guohan Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guohan Hu more than expected).
Fields of papers citing papers by Guohan Hu
This network shows the impact of papers produced by Guohan Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guohan Hu. The network helps show where Guohan Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Guohan Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 163 | |
| 2 | 2011 | 78 | |
| 3 | 2010 | 74 | |
| 4 | 2013 | 66 | |
| 5 | 2011 | 53 | |
| 6 | Down-regulation of long non-coding RNA FOXD3 antisense RNA 1 (FOXD3-AS1) inhibits cell proliferation, migration, and invasion in malignant glioma cells. | 2016 | 48 |
| 7 | Differential lncRNA expression profiles in recurrent gliomas compared with primary gliomas identified by microarray analysis. | 2015 | 45 |
| 8 | 2008 | 43 | |
| 9 | 2012 | 42 | |
| 10 | 2011 | 42 | |
| 11 | 2009 | 38 | |
| 12 | 2014 | 37 | |
| 13 | 2015 | 36 | |
| 14 | 2011 | 36 | |
| 15 | 2014 | 34 | |
| 16 | 2013 | 33 | |
| 17 | 2005 | 33 | |
| 18 | 2012 | 32 | |
| 19 | 2013 | 28 | |
| 20 | 2011 | 28 |
About Guohan Hu
Guohan Hu is a scholar working on Molecular Biology, Cancer Research, Neurology, Oncology and Cell Biology, having authored 65 papers that have together received 1.5k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (10 papers), Ubiquitin and proteasome pathways (7 papers), Cancer-related gene regulation (6 papers), MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers), Circular RNAs in diseases (5 papers), Meningioma and schwannoma management (5 papers) and Cancer-related Molecular Pathways (5 papers). The work is most often cited by research in Cancer Research (529 citations), Molecular Biology (987 citations), Genetics (146 citations), Neurology (159 citations) and Oncology (220 citations). Guohan Hu has collaborated with scholars based in China and United States. Frequent co-authors include Yicheng Lu, Chun Luo, Juxiang Chen, Lei Jiang, Xuehua Ding, Juxiang Chen, Lijun Hou, Weiqing Li, Zheng Cai and Huimin Liu. Their work appears in journals such as PLoS ONE, Brain Research, Cellular and Molecular Neurobiology, Journal of Neuro-Oncology and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.